Your browser doesn't support javascript.
loading
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach.
Lauder, Sarah N; Vanhaesebroeck, Bart; Gallimore, Awen.
Affiliation
  • Lauder SN; Division of Infection and Immunity, Cardiff University School of Medicine, SIURI, Cardiff, UK. LauderSN@cardiff.ac.uk.
  • Vanhaesebroeck B; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.
  • Gallimore A; Division of Infection and Immunity, Cardiff University School of Medicine, SIURI, Cardiff, UK.
Br J Cancer ; 125(4): 467-469, 2021 08.
Article in En | MEDLINE | ID: mdl-33824480
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antigens, CD / Class I Phosphatidylinositol 3-Kinases / Immune Checkpoint Inhibitors / Neoplasms Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antigens, CD / Class I Phosphatidylinositol 3-Kinases / Immune Checkpoint Inhibitors / Neoplasms Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: Country of publication: